Dong Fang Liu
Direttore Tecnico/Scientifico/R&S presso NUVATION BIO INC.
Patrimonio netto: 15 720 $ in data 30/04/2024
Posizioni attive di Dong Fang Liu
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NUVATION BIO INC. | Direttore Tecnico/Scientifico/R&S | 18/07/2022 | - |
Storia della carriera di Dong Fang Liu
Precedenti posizioni note di Dong Fang Liu
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| 3D MEDICINES INC. | Direttore Tecnico/Scientifico/R&S | 11/01/2019 | 01/03/2021 |
| CELGENE | Direttore/Membro del Consiglio | - | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
Formazione di Dong Fang Liu
| Beijing Medical University | Undergraduate Degree |
| University of Toledo (Ohio) | Graduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Cina | 3 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| 3D MEDICINES INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| NUVATION BIO INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Borsa valori
- Insiders
- Dong Fang Liu
- Esperienza